Russell Investments Group, Ltd. Stoke Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$11.03 - $17.52 $16,842 - $26,753	1,527 New	1,527 $20,000
Q3 2022 Nov 04, 2022	SELL	$12.56 - $22.53 $9,897 - $17,753	-788 Reduced 36.31%	1,382 $17,000
Q2 2022 Jul 29, 2022	BUY	$10.36 - $23.93 $22,481 - $51,928	2,170 New	2,170 $28,000
Q1 2022 May 05, 2022	SELL	$17.19 - $26.1 $228,850 - $347,469	-13,313 Closed	0 $0
Q4 2021 Jan 21, 2022	BUY	$18.11 - $30.72 $241,098 - $408,975	13,313 New	13,313 $319,000

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $386M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.